<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>315048</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>7542549</PubmedId>
            <Abstract>We previously identified an HLA-B8+ donor, NW, whose lymphoblastoid cells failed to present a B8-restricted epitope from the influenza A nucleoprotein following viral infection, although added peptide could still be presented. The failure to present through HLA-B8 following viral infection appears to be specific for the NP epitope. Here, we report that donor NW makes an HLA-B2702-restricted influenza-specific CTL response to an epitope in the nucleoprotein that overlaps the B8-restricted epitope by 8 aa. Two mechanisms for the failure of this cell line to present the B8-restricted epitope following viral infection are investigated. One is that there is an antigen processing polymorphism specific to the NW cell line, so that there is either preferential generation or preferential transport of the B2702 epitope. The other is that B8 and B2702 compete for a common peptide fragment in the ER and this leads to suboptimal loading of HLA-B8.</Abstract>
            <ArticleYear>1995</ArticleYear>
            <ArticlePages>65-77</ArticlePages>
            <ArticleTitle>Different MHC class I alleles compete for presentation of overlapping viral epitopes.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Tussey</LastName>
                    <ForeName>L G</ForeName>
                </Author>
                <Author>
                    <LastName>Rowland-Jones</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Zheng</LastName>
                    <ForeName>T S</ForeName>
                </Author>
                <Author>
                    <LastName>Androlewicz</LastName>
                    <ForeName>M J</ForeName>
                </Author>
                <Author>
                    <LastName>Cresswell</LastName>
                    <ForeName>P</ForeName>
                </Author>
                <Author>
                    <LastName>Frelinger</LastName>
                    <ForeName>J A</ForeName>
                </Author>
                <Author>
                    <LastName>McMichael</LastName>
                    <ForeName>A J</ForeName>
                </Author>
            </Authors>
            <Affiliations>Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, England.</Affiliations>
            <ArticleChemicalList>Antigens, Viral;Epitopes;HLA-B8 Antigen;Histocompatibility Antigens Class I</ArticleChemicalList>
            <ArticleMeshHeadingsList>Alleles; Antigen Presentation; Antigens, Viral(immunology); Clone Cells; Epitopes(immunology); HLA-B8 Antigen(immunology); Histocompatibility Antigens Class I(genetics; immunology); Humans; T-Lymphocytes, Cytotoxic(cytology; immunology)</ArticleMeshHeadingsList>
            <Comments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/) and from the HLA Ligand Database (http://hlaligand.ouhsc.edu/)</Comments>
            <Journal>
                <Volume>3</Volume>
                <Issue>1</Issue>
                <Title>Immunity</Title>
                <Issn>1074-7613</Issn>
                <MedlineTa>Immunity</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>NP381-388</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LRSRYWAI</LinearSequence>
                        <StartingPosition>381</StartingPosition>
                        <EndingPosition>388</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q91UL1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>132504</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>39214</EpitopeId>
                <ReferenceStartingPosition>381</ReferenceStartingPosition>
                <ReferenceEndingPosition>388</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/) and from the HLA Ligand Database (http://hlaligand.ouhsc.edu/). P000380 (FIMM database epitope ID). Recurated by IEDB Curation Staff.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1A</LocationOfData>
                        <TCellId>315235</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>PBMC were isolated from donor NW following natural influenza A virus infection.  Influenza-specific bulk cultures were established using influenza A virus AX/31.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>C1R cells-B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>187</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP381-388</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LRSRYWAI</LinearSequence>
                                        <StartingPosition>381</StartingPosition>
                                        <EndingPosition>388</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q91UL1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>132504</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Target cells were C1R cells transfected with HLA-B2702.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP380-388</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ELRSRYWAI</LinearSequence>
                        <StartingPosition>380</StartingPosition>
                        <EndingPosition>388</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q91UL1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>132504</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>13263</EpitopeId>
                <ReferenceStartingPosition>380</ReferenceStartingPosition>
                <ReferenceEndingPosition>388</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <TCellId>1007851</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ELRSRYWAI</LinearSequence>
                                            <StartingPosition>380</StartingPosition>
                                            <EndingPosition>388</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q91UL1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>PBMC were isolated from donor HR.  Natural exposure to influenza A virus infection is assumed.  Peptide-specific CTL clones were established by restimulation with peptide-pulsed B-LCL and limiting dilution.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>HR4</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>301</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Truncated NP gene (residues 1, 2, 327-498)</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QLVWMACHSAAFEDLRVLSFIKGTKVLPRGKLSTRGVQIASNENMETMESSTLELRSRYWAIRTRSGGNTNQ</LinearSequence>
                                        <StartingPosition>327</StartingPosition>
                                        <EndingPosition>398</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q91UL1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>132504</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <RecombinantOrganism>
                                    <SubType>Recombinant Organism</SubType>
                                    <RecombinantOrganismId>10245</RecombinantOrganismId>
                                </RecombinantOrganism>
                            </AntigenContainingObject>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>A B8-restricted CTL line shown to recognize peptide-pulsed APCs fails to recognize NP-transfected cells that coexpress B8 and B*2702. A mutation that abolishes peptide binding to B*2702 restores the ability of B8-restricted cells to recognize NP-transfected cells, implying competition for peptide presentation by these two MHC alleles. .</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>1007797</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ELRSRYWAI</LinearSequence>
                                            <StartingPosition>380</StartingPosition>
                                            <EndingPosition>388</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q91UL1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>PBMC were isolated from donor HW.  Natural exposure to influenza A virus infection is assumed.  Peptide-specific CTL clones were established by restimulation with peptide-pulsed B-LCL and limiting dilution.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AssayedTcrMolecule>
                            <AssayedTcrMoleculeName>HW5</AssayedTcrMoleculeName>
                        </AssayedTcrMolecule>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>301</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP380-388</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ELRSRYWAI</LinearSequence>
                                        <StartingPosition>380</StartingPosition>
                                        <EndingPosition>388</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q91UL1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>132504</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>1</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>NP residue 80 is required for B8-restricted CTL recognition since the truncated peptide NP381-388 failed to induce a cytotoxic response.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig. 4A</LocationOfData>
                        <MhcBindingId>1007812</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>C1R cells transfected with HLA-B8 were used in the binding assay.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>301</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig. 4A</LocationOfData>
                        <MhcBindingId>1007814</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>C1R cells transfected with HLA-B*2702 were used in the binding assay.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>187</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig. 4A</LocationOfData>
                        <MhcBindingId>1008458</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>C1R cells transfected with HLA-B7 were used in the binding assay.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>300</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP380-388 (K)</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ELKSRYWAI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <LocationOfData>Page 68</LocationOfData>
                <EpitopeId>13142</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This analog contains a R382K substitution of the naturally occurring influenza NP380-388 (ELRSRYWAI) peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig. 4B</LocationOfData>
                        <MhcBindingId>1007850</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>C1R cells transfected with HLA-B*2702 were used in the binding assay.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>187</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig. 4B</LocationOfData>
                        <MhcBindingId>1007849</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>C1R cells transfected with HLA-B8 were used in the binding assay.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>301</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Fig. 4B</LocationOfData>
                        <MhcBindingId>1008459</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>C1R cells transfected with HLA-B7 were used in the binding assay.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>300</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

